Omeprazolsynthese für Protonenpumpenhemmer

Kontrolle der Magensäure durch chirale Selektivchemie

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

Übersicht

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

Chemischer Prozess

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

Rohstoffe

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

Endprodukte

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

Sicherheitshinweise

Neuere Innovationen

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

Produktionsmaßstab

800

Tonnen/Jahr

$3.5 billion

Marktwert

Mehr in Pharmaceutical & Drug Manufacturing

Aspirinsynthese durch Acetylierung von Salicylsäure

Global Industrial Scale

Halbsynthetische Produktion von Amoxicillin

Global Industrial Scale

Ibuprofensynthese – BHC-Grünprozess

Global Industrial Scale

Paracetamol-Synthese

Global Industrial Scale

Penicillin-G-Herstellung durch Fermentation

Global Industrial Scale

Produktion von rekombinantem humanem Insulin

Global Industrial Scale

Synthese von Metforminhydrochlorid

Global Industrial Scale

Frequently Asked Questions

What industry uses Omeprazolsynthese für Protonenpumpenhemmer?
Omeprazolsynthese für Protonenpumpenhemmer is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Omeprazolsynthese für Protonenpumpenhemmer?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of Omeprazolsynthese für Protonenpumpenhemmer?
Omeprazolsynthese für Protonenpumpenhemmer has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of Omeprazolsynthese für Protonenpumpenhemmer?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in Omeprazolsynthese für Protonenpumpenhemmer?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).